Samil Pharm (000520) - Total Liabilities

Latest as of June 2025: ₩226.31 Billion KRW ≈ $153.37 Million USD

Based on the latest financial reports, Samil Pharm (000520) has total liabilities worth ₩226.31 Billion KRW (≈ $153.37 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Samil Pharm annual equity growth to track the company's year-over-year net asset growth rate.

Samil Pharm - Total Liabilities Trend (2011–2024)

This chart illustrates how Samil Pharm's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Samil Pharm generate to measure how efficiently the company converts operating cash flow to free cash.

Samil Pharm Competitors by Total Liabilities

The table below lists competitors of Samil Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
CLERHP Estructuras S.A MC:CLR	Spain	€74.25 Million
MEI Pharma Inc NASDAQ:MEIP	USA	$1.35 Million
Studentbostader I Sverige AB ST:STUDBO	Sweden	Skr5.90 Billion
Apex Biotechnology Corp TW:1733	Taiwan	NT$494.69 Million
Asefa Public Company Limited BK:ASEFA	Thailand	฿2.43 Billion
Iris Clothings Limited NSE:IRISDOREME	India	Rs478.31 Million
EcoFirst Consolidated Bhd KLSE:3557	Malaysia	RM406.65 Million
Westag & Getalit ST O.N. F:WUG	Germany	€47.09 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Samil Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 000520 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.52	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Samil Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Samil Pharm (2011–2024)

The table below shows the annual total liabilities of Samil Pharm from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩218.95 Billion ≈ $148.38 Million	-9.84%
2023-12-31	₩242.85 Billion ≈ $164.58 Million	+5.19%
2022-12-31	₩230.88 Billion ≈ $156.46 Million	+43.71%
2021-12-31	₩160.66 Billion ≈ $108.88 Million	+25.41%
2020-12-31	₩128.11 Billion ≈ $86.82 Million	+5.35%
2019-12-31	₩121.60 Billion ≈ $82.41 Million	+32.37%
2018-12-31	₩91.87 Billion ≈ $62.26 Million	+8.96%
2017-12-31	₩84.31 Billion ≈ $57.14 Million	+75.19%
2016-12-31	₩48.12 Billion ≈ $32.61 Million	+7.18%
2015-12-31	₩44.90 Billion ≈ $30.43 Million	-15.08%
2014-12-31	₩52.88 Billion ≈ $35.83 Million	+15.75%
2013-12-31	₩45.68 Billion ≈ $30.96 Million	-5.07%
2012-12-31	₩48.12 Billion ≈ $32.61 Million	-11.86%
2011-12-31	₩54.60 Billion ≈ $37.00 Million	--

About Samil Pharm

KO:000520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$100.71 Million

₩148.61 Billion KRW

Market Cap Rank

#19179 Global

#929 in Korea

Share Price

₩7000.00

Change (1 day)

-0.85%

52-Week Range

₩5830.00 - ₩12310.00

All Time High

₩23603.13